Cormorant Asset Management, LLC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Cormorant Asset Management, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Cormorant Asset Management, LLC. Cormorant Asset Management, LLC is a 10% Owner in PROTEOSTASIS THERAPEUTICS, INC. ($PTI) and a 10% Owner in Apellis Pharmaceuticals, Inc. ($APLS) and a in Atea Pharmaceuticals, Inc. ($AVIR) and a in Avidity Biosciences, Inc. ($RNA) and a 10% Owner in Axonics Modulation Technologies, Inc. ($AXNX) and a 10% Owner in Turning Point Therapeutics, Inc. ($TPTX) and a 10% Owner in Kezar Life Sciences, Inc. ($KZR) and a in Prometheus Biosciences, Inc. ($RXDX) and a in Rain Therapeutics Inc. ($RAIN) and a 10% Owner in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and a in Olema Pharmaceuticals, Inc. ($OLMA) and a in BioAtla, Inc. ($BCAB) and a Director in Biomea Fusion, Inc. ($BMEA).
Address: 100 HIGH STREET, SUITE 1105 BOSTON 02110 MA
Companies in which Cormorant Asset Management, LLC is an Insider
Apellis Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Cormorant Asset Management, LLC: 10% Owner
Holdings: 2,402,497 shares
Latest Transaction: Nov 14 2017
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Atea Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Cormorant Asset Management, LLC:
Holdings: 6,411,355 shares
Latest Transaction: Nov 05 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Avidity Biosciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Cormorant Asset Management, LLC:
Holdings: 2,214,545 shares
Latest Transaction: Jun 18 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Axonics, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Cormorant Asset Management, LLC: 10% Owner
Holdings: 599,999 shares
Latest Transaction: Nov 02 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BioAtla, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Cormorant Asset Management, LLC:
Holdings: 1,492,060 shares
Latest Transaction: Dec 22 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Biomea Fusion, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Cormorant Asset Management, LLC: Director
Holdings: 0 shares
Latest Transaction: Apr 19 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Kezar Life Sciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Cormorant Asset Management, LLC: 10% Owner
Holdings: 315,488 shares
Latest Transaction: Jun 27 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Kiniksa Pharmaceuticals, Ltd.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Cormorant Asset Management, LLC: 10% Owner
Holdings: 830,999 shares
Latest Transaction: May 31 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Olema Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Cormorant Asset Management, LLC:
Holdings: 2,845,544 shares
Latest Transaction: Nov 23 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Prometheus Biosciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Cormorant Asset Management, LLC:
Holdings: 1,848,022 shares
Latest Transaction: Mar 18 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Rain Therapeutics Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Cormorant Asset Management, LLC:
Holdings: 2,326,657 shares
Latest Transaction: Apr 29 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Turning Point Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Cormorant Asset Management, LLC: 10% Owner
Holdings: 3,122,367 shares
Latest Transaction: May 16 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
YUMANITY THERAPEUTICS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Cormorant Asset Management, LLC: 10% Owner
Holdings: 3,300,000 shares
Current Value: $49,104,000
Latest Transaction: Dec 18 2017
$YMTX Market Capitalization: $367.66M
$YMTX Previous Close: $14.88
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Cormorant Asset Management, LLC
Sentiment: All, APLS, AVIR, RNA, AXNX, BCAB, BMEA, KZR, KNSA, OLMA, RXDX, RAIN, TPTX, YMTX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29 2021 | RAIN | Rain Therapeutics ... | Cormorant Asset Management, LP | Option Exercise | C | 0.00 | 2,512,561 | 0 | 0 | ||
| Apr 29 2021 | RAIN | Rain Therapeutics ... | Cormorant Asset Management, LP | Buy | P | 17.00 | 450,000 | 7,650,000 | 2,776,657 | 2.3 M to 2.8 M (+19.34 %) | |
| Apr 29 2021 | RAIN | Rain Therapeutics ... | Cormorant Asset Management, LP | Buy | C | 0.00 | 2,326,657 | 0 | 2,326,657 | 0 to 2.3 M | |
| Apr 19 2021 | BMEA | Biomea Fusion, Inc ... | Cormorant Asset Management, LP | Director | Option Exercise | A | 17.00 | 28,911 | 491,487 | 28,911 | |
| Mar 18 2021 | RXDX | Prometheus Bioscie ... | Cormorant Asset Management, LP | Option Exercise | C | 0.00 | 1,084,696 | 0 | 0 | ||
| Mar 18 2021 | RXDX | Prometheus Bioscie ... | Cormorant Asset Management, LP | Option Exercise | C | 0.00 | 763,327 | 0 | 0 | ||
| Mar 18 2021 | RXDX | Prometheus Bioscie ... | Cormorant Asset Management, LP | Buy | P | 19.00 | 375,000 | 7,125,000 | 2,223,022 | 1.8 M to 2.2 M (+20.29 %) |
View all Cormorant Asset Management, LLC insider transactions.